 |
fingolimod |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic inflammatory demyelinating polyneuropathy |
| USA Market Approval | USA |
| USA Designation Date | 2010-04-30 00:00:00 |
| Sponsor | Novartis Pharmaceutical Corporation;One Health Plaza;East Hanover, New Jersey, 07936 |
| |
fingolimod |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic inflammatory demyelinating polyneuropathy |
| USA Market Approval | USA |
| USA Designation Date | 2010-04-30 00:00:00 |
| Sponsor | Novartis Pharmaceutical Corporation;One Health Plaza;East Hanover, New Jersey, 07936 |